America's Best Nonprofits
  1. Home
  2. Medical Research
  3. Arlington, VA
  4. Medical Device Innovation Consortium

Medical Device Innovation Consortium

Medical Device Innovation Consortium has an America's Best Score of 47 out of 100, based on its 2024 Form 990, below the 60-point bar to be ranked.

  • Arlington, VA
  • Tax-exempt since 2014
  • EIN: 46-1465348
mdic.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
47OF 100 Not ranked Below the 60-point bar How this score is calculated

Organization summary

Medical Device Innovation Consortium is a 501(c)(3) organization, classified under Medical Research (NTEE H99). Contributions are tax-deductible.

1655 Fort Myer Dr Ste 250, Arlington, VA 22209-3120

Among the 3 scored medical research organizations in Arlington, Medical Device Innovation Consortium holds 0.9 months of operating reserves (peer median 12.6 months), runs a typical yearly deficit of 4.7% (peers: deficit of 1.2%), and has grown spending 40.6% a year (peers: grown spending 17.5% a year).

In fiscal year 2024 it reported $28,171,331 in revenue and $28,147,444 in expenses, with contributions making up 80.5% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2024 Form 990

Break down barriers in the medical technology life cycle to accelerate innovation and adoption of safe, effective and high-quality medical technologies.

Largest programs · fiscal year 2024

  • National evaluation system for health technology coordinating center:the national evaluation system for health technology (nest) is an initiative of mdic which serves as a catalyst in establishing functional and efficient pathways for key stakeholders to generate lower-cost, nearer real-time real-world evidence (rwe) of sufficient quality for regulatory, coverage, patient, and clinical decision-ma… Read more

    National evaluation system for health technology coordinating center:the national evaluation system for health technology (nest) is an initiative of mdic which serves as a catalyst in establishing functional and efficient pathways for key stakeholders to generate lower-cost, nearer real-time real-world evidence (rwe) of sufficient quality for regulatory, coverage, patient, and clinical decision-making. By solving the challenges that have slowed medical device innovation, delayed the detection of safety signals, and created inefficiencies, nestcc could improve patients' timely access to safe medical devices and their quality of life.

    $15,109,411 spent · 65.9% of program spending
  • Science and technology:science and technology's focus involves developing tools and methods to enhance efficiency (in terms of time and resources), quality, design, manufacturing, and a predictable pathway in data collection and evidence development. The organization's clinical science program aims to improve diagnostic testing and product development by supporting manufacturers in obtaining credi… Read more

    Science and technology:science and technology's focus involves developing tools and methods to enhance efficiency (in terms of time and resources), quality, design, manufacturing, and a predictable pathway in data collection and evidence development. The organization's clinical science program aims to improve diagnostic testing and product development by supporting manufacturers in obtaining credible clinical evidence patient preferences and facilitating first-in-world patient access to safe and effective new technologies of significant health importance.

    $6,521,269 spent · 28.4% of program spending
  • Health economics and patient value:mdic's value-based healthcare projects are developed to improve the industry's ability to real world evidence and include patient perspectives in the development, pre-market approval, and post-market evaluation of medical devices and support a more predictable pathway in reimbursement decisions under federal healthcare programs. $744,488 spent · 3.2% of program spending
  • Development and membership $563,698 spent · 2.5% of program spending

Where each dollar went · fiscal year 2024

Of every dollar it spent, 81¢ went to programs, 19¢ to management and 0¢ to fundraising.

  • Programs $22,938,866
  • Management $5,208,578
  • Fundraising $0

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score47 / 100
DesignationNot ranked

Score breakdown

MeasureThis organizationPoints
Operating reserves0.9 mo; 1.3 mo in cash0.6 / 25
Financial balance (median margin)−4.7%6.8 / 20
Transparency3 full 990s, latest TY202420 / 20
Program growth+40.6% / yr15 / 15
Track record12 years4.8 / 10
Debt load82.1% of assets0 / 10
Total47.3 → 47
Spending on programs
Not scored; America's Best needs 65%+
82%Meets

Compared with Arlington peers

MeasureThis organizationPeer median
Operating reserves0.9 mo12.6 mo
Typical margin−4.7%−1.2%
Spending growth+40.6% / yr+17.5% / yr
Debt load82.1%29.0%

Peers: the 3 Arlington medical research organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$28,171,331Fiscal year 20242022: $10,710,90920222023: $14,899,71220232024: $28,171,3312024
Expenses$28,147,444Fiscal year 20242022: $14,247,43720222023: $15,639,93620232024: $28,147,4442024
Total assets$11,814,781Fiscal year 20242022: $11,514,04020222023: $11,871,42020232024: $11,814,7812024
Total liabilities$9,698,496Fiscal year 20242022: $8,681,41820222023: $9,779,02220232024: $9,698,4962024
Fiscal year ending December 2024
Revenue$28,171,331
Expenses$28,147,444
Net income$23,887
Net assets$2,116,285

Notable sources of revenue

Percent of total revenue
Contributions$22,684,960
Program services$5,459,148
Investment income$27,223
Other (net)$0

Assets / debt

Total assets$11,814,781
Total liabilities$9,698,496
Net assets$2,116,285

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$14,899,712
Expenses$15,639,936
Net income−$740,224
Net assets$2,092,398

Notable sources of revenue

Percent of total revenue
Contributions$9,899,161
Program services$4,974,275
Investment income$26,276
Other (net)$0

Assets / debt

Total assets$11,871,420
Total liabilities$9,779,022
Net assets$2,092,398

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$10,710,909
Expenses$14,247,437
Net income−$3,536,528
Net assets$2,832,622

Notable sources of revenue

Percent of total revenue
Contributions$10,002,314
Program services$1,688,525
Investment income$12,404
Other (net)−$992,334

Assets / debt

Total assets$11,514,040
Total liabilities$8,681,418
Net assets$2,832,622

Compensation

Officers and key employees$3,006,669
Share of expenses21.1%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?